Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials
Abstract
This systematic review and meta-analysis of randomized controlled trials (RCTs) of intensive care unit (ICU) patients with pneumonia was conducted to compare the clinical outcomes of beta-lactam antibiotics when administered by prolonged infusion vs intermittent infusion. The systematic search was conducted in Medline (via PubMed), CINAHL, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov. The outcomes were mortality, clinical cure rate, microbiological cure rate, adverse events, and ICU length of stay. The pooled risk ratios or mean differences were estimated by the fixed or random effect methods according to heterogeneity statistics. Twelve eligible RCTs were included in the meta-analysis. ICU length of stay was lower in the prolonged infusion patients compared with intermittent infusion. However, compared to intermittent infusion, the prolonged infusion, both continuous and extended infusion, of beta-lactam antibiotics was not associated with statistically significant improvements in mortality, clinical cure rate, microbiological cure rate, and rate of adverse events. For the treatment of ICU patients with pneumonia, prolonged infusion was associated with a shorter ICU length of stay. Multicenter RCTs with large sample sizes of ICU patients with pneumonia are needed to better assess other important endpoints.
Related
- Ginkgo biloba Extract for Intermittent Claudication in Patients with Peripheral Arterial Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
- Preoperative antibiotics for mild or moderate acute cholecystitis (POMMAC): study protocol for a non-inferiority, open-label, randomized controlled trial.
- Prophylactic antibiotics for pancreaticoduodenectomy: study protocol for a multicenter randomized controlled trial comparing tazobactam/piperacillin versus ampicillin/sulbactam.
- Advantage of cerebellar intermittent theta-burst stimulation in Alzheimer's disease (ACT-AD): study protocol for a multicenter, randomized, double-blind, sham-controlled trial
- Continuous infusion versus intermittent infusion of vancomycin: a systematic review and meta-analysis with a focus on nephrotoxicity, target attainment, and clinical outcomes
BibTeX
@article{li2026continuous,
title = {{Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials}},
author = {Yi-Xuan Li and Jason A. Roberts and Mohd Abdul-Aziz and Fekade Sime},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
month = oct,
doi = {10.1128/aac.00732-25},
url = {https://hal.science/hal-05805224v1},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Continuous or extended vs intermittent infusions of beta-lactam antibiotics in ICU patients with pneumonia: a systematic review and meta-analysis of randomized controlled trials
AU - Yi-Xuan Li
AU - Jason A. Roberts
AU - Mohd Abdul-Aziz
AU - Fekade Sime
PY - 2026
DA - 2026/10/19
JO - Antimicrobial Agents and Chemotherapy
DO - 10.1128/aac.00732-25
UR - https://hal.science/hal-05805224v1
AB - This systematic review and meta-analysis of randomized controlled trials (RCTs) of intensive care unit (ICU) patients with pneumonia was conducted to compare the clinical outcomes of beta-lactam antibiotics when administered by prolonged infusion vs intermittent infusion. The systematic search was conducted in Medline (via PubMed), CINAHL, EMBASE, Cochrane Central Register of Controlled Trials (CENTRAL), and ClinicalTrials.gov. The outcomes were mortality, clinical cure rate, microbiological cure rate, adverse events, and ICU length of stay. The pooled risk ratios or mean differences were estimated by the fixed or random effect methods according to heterogeneity statistics. Twelve eligible RCTs were included in the meta-analysis. ICU length of stay was lower in the prolonged infusion patients compared with intermittent infusion. However, compared to intermittent infusion, the prolonged infusion, both continuous and extended infusion, of beta-lactam antibiotics was not associated with statistically significant improvements in mortality, clinical cure rate, microbiological cure rate, and rate of adverse events. For the treatment of ICU patients with pneumonia, prolonged infusion was associated with a shorter ICU length of stay. Multicenter RCTs with large sample sizes of ICU patients with pneumonia are needed to better assess other important endpoints.
SN - 0066-4804
SN - 1098-6596
ER -